BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37459583)

  • 21. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
    Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer.
    Im C; Neupane A; Baedke JL; Lenny B; Delaney A; Dixon SB; Chow EJ; Mostoufi-Moab S; Yang T; Richard MA; Gramatges MM; Lupo PJ; Sharafeldin N; Bhatia S; Armstrong GT; Hudson MM; Ness KK; Robison LL; Yasui Y; Wilson CL; Sapkota Y
    J Clin Oncol; 2024 Apr; ():JCO2302281. PubMed ID: 38652878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.
    Friedman DN; Goodman PJ; Leisenring WM; Diller LR; Cohn SL; Howell RM; Smith SA; Tonorezos ES; Wolden SL; Neglia JP; Ness KK; Gibson TM; Nathan PC; Turcotte LM; Weil BR; Robison LL; Oeffinger KC; Armstrong GT; Sklar CA; Henderson TO
    J Natl Cancer Inst; 2024 Jun; 116(6):885-894. PubMed ID: 38460547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-Genome Sequencing of Childhood Cancer Survivors Treated with Cranial Radiation Therapy Identifies 5p15.33 Locus for Stroke: A Report from the St. Jude Lifetime Cohort Study.
    Sapkota Y; Cheung YT; Moon W; Shelton K; Wilson CL; Wang Z; Mulrooney DA; Zhang J; Armstrong GT; Hudson MM; Robison LL; Krull KR; Yasui Y
    Clin Cancer Res; 2019 Nov; 25(22):6700-6708. PubMed ID: 31462438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer.
    Sapkota Y; Li N; Pierzynski J; Mulrooney DA; Ness KK; Morton LM; Michael JR; Zhang J; Bhatia S; Armstrong GT; Hudson MM; Robison LL; Yasui Y
    JACC CardioOncol; 2021 Mar; 3(1):76-84. PubMed ID: 33842896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer.
    Ghosh T; Chen Y; Dietz AC; Armstrong GT; Howell RM; Smith SA; Mulrooney DA; Turcotte LM; Yuan Y; Yasui Y; Neglia JP
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2235-2243. PubMed ID: 34526300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Genome-Wide Polygenic Score to Risk of Coronary Artery Disease in Childhood Cancer Survivors.
    Sapkota Y; Liu Q; Li N; Bhatt NS; Ehrhardt MJ; Wilson CL; Wang Z; Jefferies JL; Zhang J; Armstrong GT; Hudson MM; Robison LL; Mulrooney DA; Yasui Y
    JACC CardioOncol; 2022 Jun; 4(2):258-267. PubMed ID: 35818558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
    Man TK; Aubert G; Richard MA; LeJeune W; Hariri E; Goltsova T; Gaikwad A; Chen Y; Whitton J; Leisenring WM; Arnold MA; Neglia JP; Yasui Y; Robison LL; Armstrong GT; Bhatia S; Gramatges MM
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):453-460. PubMed ID: 34782395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.
    Chen C; Qin N; Wang M; Dong Q; Tithi SS; Hui Y; Chen W; Wu G; Kennetz D; Edmonson MN; Rusch MC; Thrasher A; Easton J; Mulder HL; Song N; Plonski NM; Shelton K; Im C; Ehrhardt MJ; Nichols KE; Leisenring WM; Stratton KL; Howell R; Yasui Y; Bhatia S; Armstrong GT; Ness KK; Hudson MM; Zhang J; Wang H; Srivastava DK; Robison LL; Wang Z
    Lancet Oncol; 2023 Oct; 24(10):1147-1156. PubMed ID: 37797633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
    Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
    J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.
    Armstrong GT; Liu W; Leisenring W; Yasui Y; Hammond S; Bhatia S; Neglia JP; Stovall M; Srivastava D; Robison LL
    J Clin Oncol; 2011 Aug; 29(22):3056-64. PubMed ID: 21709189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE).
    Clark RA; Mostoufi-Moab S; Yasui Y; Vu NK; Sklar CA; Motan T; Brooke RJ; Gibson TM; Oeffinger KC; Howell RM; Smith SA; Lu Z; Robison LL; Chemaitilly W; Hudson MM; Armstrong GT; Nathan PC; Yuan Y
    Lancet Oncol; 2020 Mar; 21(3):436-445. PubMed ID: 32066539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    Morton LM; Sampson JN; Armstrong GT; Chen TH; Hudson MM; Karlins E; Dagnall CL; Li SA; Wilson CL; Srivastava DK; Liu W; Kang G; Oeffinger KC; Henderson TO; Moskowitz CS; Gibson TM; Merino DM; Wong JR; Hammond S; Neglia JP; Turcotte LM; Miller J; Bowen L; Wheeler WA; Leisenring WM; Whitton JA; Burdette L; Chung C; Hicks BD; Jones K; Machiela MJ; Vogt A; Wang Z; Yeager M; Neale G; Lear M; Strong LC; Yasui Y; Stovall M; Weathers RE; Smith SA; Howell R; Davies SM; Radloff GA; Onel K; Berrington de González A; Inskip PD; Rajaraman P; Fraumeni JF; Bhatia S; Chanock SJ; Tucker MA; Robison LL
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
    Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
    Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
    PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency.
    Kim SH; Shin KH; Seok SO; Cho YJ; Noh JK; Suh JS; Yang WI
    Ann Surg Oncol; 2015 Mar; 22(3):859-65. PubMed ID: 25192682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
    Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
    J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.
    Turcotte LM; Neglia JP; Reulen RC; Ronckers CM; van Leeuwen FE; Morton LM; Hodgson DC; Yasui Y; Oeffinger KC; Henderson TO
    J Clin Oncol; 2018 Jul; 36(21):2145-2152. PubMed ID: 29874133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
    Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
    JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.